Mechanisms of common fragile site instability

被引:109
作者
Glover, TW [1 ]
Arlt, MF [1 ]
Casper, AM [1 ]
Durkin, SG [1 ]
机构
[1] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA
关键词
D O I
10.1093/hmg/ddi265
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The study of common fragile sites has its roots in the early cytogenetic investigations of the fragile X syndrome. Long considered an interesting component of chromosome structure, common fragile sites have taken on novel significance as regions of the genome that are particularly sensitive to certain forms of replication stress, which are frequently rearranged in cancer cells. In recent years, much has been learned about the genomic structure at fragile sites and the cellular checkpoint functions that monitor their stability. Recent findings suggest that common fragile sites may serve as markers of chromosome damage caused by replication stress during early stages of tumorigenesis. Thus, the study of common fragile sites can provide insight not only into the nature of fragile sites, but also into the broader consequences of replication stress on DNA damage and cancer. However, despite recent advances, many questions remain regarding the normal functional significance of these conserved regions and the basis of their fragility.
引用
收藏
页码:R197 / R205
页数:9
相关论文
共 102 条
  • [1] Cell cycle checkpoint signaling through the ATM and ATR kinases
    Abraham, RT
    [J]. GENES & DEVELOPMENT, 2001, 15 (17) : 2177 - 2196
  • [2] ATR couples FANCD2 monoubiquitination to the DNA-damage response
    Andreassen, PR
    D'Andrea, AD
    Taniguchi, T
    [J]. GENES & DEVELOPMENT, 2004, 18 (16) : 1958 - 1963
  • [3] BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function
    Arlt, MF
    Xu, B
    Durkin, SG
    Casper, AM
    Kastan, MB
    Glover, TW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (15) : 6701 - 6709
  • [4] Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells
    Arlt, MF
    Miller, DE
    Beer, DG
    Glover, TW
    [J]. GENES CHROMOSOMES & CANCER, 2002, 33 (01) : 82 - 92
  • [5] DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
    Bartkova, J
    Horejsi, Z
    Koed, K
    Krämer, A
    Tort, F
    Zieger, K
    Guldberg, P
    Sehested, M
    Nesland, JM
    Lukas, C
    Orntoft, T
    Lukas, J
    Bartek, J
    [J]. NATURE, 2005, 434 (7035) : 864 - 870
  • [6] Bednarek AK, 2000, CANCER RES, V60, P2140
  • [7] Bednarek AK, 2001, CANCER RES, V61, P8068
  • [8] Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B
    Boldog, F
    Gemmill, RM
    West, J
    Robinson, M
    Robinson, L
    Li, EF
    Roche, J
    Todd, S
    Waggoner, B
    Lundstrom, R
    Jacobson, J
    Mullokandov, MR
    Klinger, H
    Drabkin, HA
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (02) : 193 - 203
  • [9] INTEGRATED YAC CONTIG CONTAINING THE 3P14.2 HEREDITARY RENAL-CARCINOMA 3-8-TRANSLOCATION BREAKPOINT AND THE FRAGILE SITE FRA3B
    BOLDOG, FL
    WAGGONER, B
    GLOVER, TW
    CHUMAKOV, I
    LEPASLIER, D
    COHEN, D
    GEMMILL, RM
    DRABKIN, HA
    [J]. GENES CHROMOSOMES & CANCER, 1994, 11 (04) : 216 - 221
  • [10] Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint
    Byun, TS
    Pacek, M
    Yee, MC
    Walter, JC
    Cimprich, KA
    [J]. GENES & DEVELOPMENT, 2005, 19 (09) : 1040 - 1052